MedPath

iVeena Delivery Systems, Inc.

iVeena Delivery Systems, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2006-01-01
Employees
1
Market Cap
-
Website
http://www.iveenamed.com

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Efficacy of IVMED-85 on Pediatric Myopia

Phase 1
Not yet recruiting
Conditions
Myopia, Progressive
Interventions
Drug: Placebo
First Posted Date
2023-03-09
Last Posted Date
2023-09-29
Lead Sponsor
iVeena Delivery Systems, Inc.
Target Recruit Count
216
Registration Number
NCT05761795

Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus Patients

Phase 1
Completed
Conditions
Keratoconus
Corneal Ectasia
Interventions
Other: Placebo
First Posted Date
2022-02-15
Last Posted Date
2022-02-15
Lead Sponsor
iVeena Delivery Systems, Inc.
Target Recruit Count
38
Registration Number
NCT05241145
Locations
🇲🇽

Codet Vision Institute, Tijuana, Baja California, Mexico

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.